Form 8-K DEXCOM INC For: Jul 30

Go back to Form 8-K DEXCOM INC For: Jul 30

DexCom (DXCM) PT Raised to $125 at Oppenheimer

August 2, 2018 9:29 AM EDT

Oppenheimer raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $85.00) while maintaining an Outperform rating.

Analyst Steven Lichtman commented, "DexCom's 2Q18 sales of $243M (+41% cc) delivered a strong beat versus our/consensus $202/$206M forecasts, led by robust outperformance in both US and... More

DexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr

August 2, 2018 7:59 AM EDT

Cowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.

Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More